Treatment strategies after a single seizure: Rationale for immediate versus deferred treatment

CNS Drugs

Volumn 21, Issue 2, 2007, Pages 89-99

  Miller, Laura C ^a   Drislane, Frank W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CARBAMAZEPINE; CORTICOSTEROID; PHENYTOIN; PLACEBO;

BEHAVIOR DISORDER; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC PROCEDURE; DISEASE CONTROL; DRUG ERUPTION; HEAD INJURY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOADING DRUG DOSE; LONG TERM CARE; MULTIPLE SCLEROSIS; NEUROSURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEIZURE; STROKE; THERAPY DELAY; TONIC CLONIC SEIZURE; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; COST-BENEFIT ANALYSIS; DRUG ADMINISTRATION SCHEDULE; HUMANS; RECURRENCE; RISK ASSESSMENT; SEIZURES;

EID: 33846968771     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200721020-00001     Document Type: Review

References (65)

1. Hauser WA. Should people be treated after a first seizure? Arch Neurology 1986; 43: 1287-8
2. Elwes RDC, Reynolds EH. Should people be treated after a first seizure? Arch Neurology 1988; 45: 490-1
3. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993; 34: 592-6
4. Scheepers B, Clough P, Pickles C. The misdiagnosis of epilepsy: findings of a population study. Seizure 1998; 7: 403-6
5. Smith D, Defalla BA, Chadwick DW. The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. QJM 1999; 92: 15-23
6. Van Donselaar CA, Geerts AT, Habbema JDF, et al. Reliability of the diagnosis of a first seizure. Neurology 1989; 39: 267-71
7. Jallon P, Loiseau P, Loiseau J. Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Epilepsia 2001; 42: 464-75
8. Hauser WA, Anderson VE, Loewenson RB, et al. Seizure recurrence after a first unprovoked seizure. N Engl J Med 1982; 307: 522-8
9. Elwes RDC, Chesterman P, Reynolds EH. Prognosis after a first untreated tonic-clonic seizure. Lancet 1985; II: 752-3
10. Shinnar S, Berg AT, Moshe SL, et al. The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics 1996; 98: 216-25
11. Stroink A, Brouwer OF, Arts WF, et al. The first unprovoked, untreated seizure in childhood: a hospital based study of the accuracy of the diagnosis, rate of recurrence, and long term outcome after recurrence. Dutch Study of Epilepsy in Childhood. J Neurol Neurosurg Psychiatry 1998; 64: 595-600
12. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 1991; 41: 965-72
13. Hauser WA, Rich SS, Lee JRJ, et al. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998; 338: 429-34
14. Shinnar S, Berg AT, O'Dell C, et al. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol 2000; 48: 140-7
15. Gilad R, Lampl Y, Gabbay U, et al. Early treatment of a single generalized tonic-clonic seizure to prevent recurrence. Arch Neurol 1996; 53: 1149-52
16. First Seizure Trial Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology 1993; 43: 478-83
17. Musicco M, Beghi E, Solari A, et al. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. Neurology 1997; 49: 991-8
18. Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomized controlled trial. Medical Research Council MESS Study Group. Lancet 2005; 365: 2007-13
19. Feksi AT, Kaamugisha J, Sander JWAS, et al. Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. Lancet 1991; 337: 406-9
20. Berg AT, Shinnar S. Do seizures beget seizures? An assessment of the clinical evidence in humans. J Clin Neurophysiol 1997; 14: 102-10
21. MacDonald BK, Johnson AL, Goodridge DM, et al. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000; 48: 833-41
22. Kaplan PW. Reproductive health effects and teratogenicity of antiepileptic drugs. Neurology 2004; 63 Suppl. 4: S13-23
23. Kilpatrick CJ, Davis SM, Tress BM, et al. Epileptic seizures in acute stroke. Arch Neurol 1990; 47: 157-60
24. Giroud M, Gras P, Fayolle H, et al. Early seizures after acute stroke: a study of 1640 cases. Epilepsia 1994; 35: 959-64
25. Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 2001; 57: 200-6
26. Arboix A, Comes E, Massons J, et al. Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology 1996; 47: 1429-35
27. Lancman ME, Golimstok A, Norscini J, et al. Risk factors for developing seizures after a stroke. Epilepsia 1993; 34: 141-3
28. Olsen TS, Høgenhaven H, Thage O. Epilepsy after stroke. Neurology 1987; 37: 1209-11
29. Burn J, Dennis M, Bamford J, et al. Epileptic seizures after a first stroke: the Oxfordshire community stroke project. BMJ 1997; 315: 1582-7
30. Sung CY, Chu NS. Epileptic seizures in thrombotic stroke. J Neurol 1990; 237: 166-70
31. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke. Arch Neurol 2000; 57: 1617-22
32. Liigant A, Haldre S, Õun A, et al. Seizure disorders in patients with brain tumors. Eur Neurol 2001; 45: 46-51
33. Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 2000; 54: 1886-93
34. Matthew E, Sherwin AL, Welner SA, et al. Seizures following intracranial surgery: incidence in the first post-operative week. Can J Neurosci 1980; 7: 285-90
35. North JB, Penhall RB, Hanieh A, et al. Phenytoin and postoperative epilepsy. J Neurosurg 1983; 58: 672-7
36. Temkin NR. Prophylactic anticonvulsants after neurosurgery. Epilepsy Curr 2002; 2: 105-7
37. Manaka S, Ishijima B, Mayanagi Y. Postoperative seizures: epidemiology, pathology, and prophylaxis. Neurol Med Chir (Tokyo) 2003; 43: 589-600
38. Annegers JF. Epidemiology and genetics of epilepsy. Neurol Clin 1994; 12: 15-29
39. Pomeroy SL, Holmes SJ, Dodge PR, et al. Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med 1990; 323: 1651-7
40. Annegers JF, Hauser WA, Beghi E, et al. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988; 38: 1407-10
41. Monteiro A, Coelho T, Stocker A. Neurocysticercosis-a review of 231 cases. Infection 1992; 20: 61-5
42. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002; 2: 751-62
43. Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002; 59: 1730-4
44. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations for the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985; 62: 475-95
45. Pascual-Sedano B, Iranzo A, Martí-Fàbregas J, et al. Prospective study of new-onset seizures in patients with human immunodeficiency virus infection. Arch Neurol 1999; 56: 609-12
46. Modi G, Modi M, Martinus I, et al. New-onset seizures associated with HIV infection. Neurology 2000; 55: 1558-61
47. Wong MC, Suite NDA, Labar DR. Seizures in human immunodeficiency virus infection. Arch Neurol 1990; 47: 640-3
48. Annegers JF, Gravow JD, Groover RV, et al. Seizures after head trauma: a population based study. Neurology 1980; 30: 683-9
49. Annegers JF, Hauser WA, Coan SP, et al. A population-based study of seizures after traumatic brain injuries. N Engl J Med 1998; 338: 20-4
50. Angeleri F, Majkowski J, Cacchiò G, et al. Posttraumatic epilepsy risk factors: one-year prospective study after head injury. Epilepsia 1999; 40: 1222-30
51. Pohlmann-Eden B, Bruckmeir J. Predictors and dynamics of posttraumatic epilepsy. Acta Neurol Scan 1997; 95: 257-62
52. Haltiner AM, Temkin NR, Dikmen SS. Risk of seizure recurrence after first late posttraumatic seizure. Arch Phys Med Rehabil 1997; 78: 835-40
53. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of phenytoin for the prevention of posttraumatic seizures. N Engl J Med 1990; 323: 497-502
54. Schierhout G, Roberts I. Prophylactic antiepileptic agents after head injury: a systematic review. J Neurol Neurosurg Psychiatry 1998; 64: 108-12
55. Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev 2001; (4): CD 000173
56. Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury. Neurology 2003; 60: 10-6
57. Mendez MF, Lim GTH. Seizures in elderly patients with dementia. Drugs Aging 2003; 20: 791-803
58. Hesdorffer DC, Hauser WA, Annegers JF, et al. Dementia and adult-onset unprovoked seizures. Neurology 1996; 46: 727-30
59. Ramsay RE, Pryor F. Epilepsy in the elderly. Neurology 2000; 55 Suppl. 1: S9-14
60. Thomas RJ. Seizures and epilepsy in the elderly. Arch Intern Med 1997; 157: 605-17
61. Vélez L, Selwa LM. Seizure disorders in the elderly. Am Fam Physician 2003; 67: 323-32
62. Sokić DV, Stojsavljević N, Drulović J, et al. Seizures in multiple sclerosis. Epilepsia 2001; 42: 72-9
63. Kinnunen E, Wikström J. Prevalence and prognosis of epilepsy in patients with multiple sclerosis. Epilepsia 1986; 27: 729-33
64. Olafson E, Benedikz J, Hauser WA. Risk of epilepsy in patients with multiple sclerosis: a population-based study in Iceland. Epilepsia 1999; 40: 745-7
65. Nyquist PA, Cascino GD, McClelland RL, et al. Incidence of seizures in patients with multiple sclerosis: a population-based study. Mayo Clin Proc 2002; 77: 910-012